Related references
Note: Only part of the references are listed.Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention
Geoffrey W. Birrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
Ngo Viet Thanh et al.
MALARIA JOURNAL (2017)
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Charles J. Woodrow et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Lead Selection of a New Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention
Marina Chavchich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Dihydroartemisinin-Piperaquine Failure in Cambodia
David L. Saunders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs
James S. McCarthy et al.
PLOS ONE (2011)
Evaluation of Artemisone Combinations in Aotus Monkeys Infected with Plasmodium falciparum
Nicanor Obaldia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
